AFP
NVO

Ausdal Financial Partners’s Novo Nordisk NVO Stock Holding History

Ausdal Financial Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$288K Buy
+8,000
New +$379K 0.01% 792

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Ausdal Financial Partners's NVO Position: Q1 2026 in Review

Ausdal Financial Partners opened a new position in Novo Nordisk (NVO) in Q1 2026: 6,070 shares worth $223K. The stake represents 0.01% of the portfolio and ranks #893 among its holdings. This is a return to the name: Ausdal Financial Partners previously reported a position in NVO as recently as Q2 2025.

Ausdal Financial Partners first reported a position in NVO in Q4 2015 and has held it in 8 quarters since. The position peaked at $628K in Q2 2025. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Ausdal Financial Partners held 6,070 shares of Novo Nordisk worth $223K as of Q1 2026.
  • Novo Nordisk was a new Ausdal Financial Partners position in Q1 2026.
  • Novo Nordisk made up 0.01% of Ausdal Financial Partners's portfolio in Q1 2026, its #893 holding.
  • Ausdal Financial Partners first reported a position in Novo Nordisk in Q4 2015 and has held it in 8 quarters since.
  • Ausdal Financial Partners's Novo Nordisk position peaked at $628K in Q2 2025.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Ausdal Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.